This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Effect of Corticosteroids

Barbara P. Lukert, MD; John S. Adams, MD

Arch Intern Med. 1976;136(11):1249-1253.

Abstract
Serum calcium and phosphorus levels, urinary excretion rates of calcium, phosphorus, and cyclic adenosine monophosphate (cAMP), and plasma parathyroid hormone (PTH) concentrations were determined in 11 normal subjects and in nine patients maintained on long-term prednisone therapy for chronic obstructive pulmonary disease. These same determinations were repeated in five of the prednisone-treated patients during the course of a seven-day calcium infusion. Prior to the infusion, the prednisonetreated patients demonstrated significantly elevated serum levels of PTH (P <.005) and increased rates of urinary phosphate and cAMP excretion (P <.005) when compared with normal subjects. After initiation of calcium infusion, the previous elevations in all of these determinations decreased to near normal levels. These data suggest that the effects of secondary hyperparathyroidism in patients maintained on long-term prednisone therapy may be overcome when calcium is administered intravenously.

(Arch Intern Med 136:1249-1253, 1976)

Author Affiliations
From the Section of Endocrinology and Metabolism, Department of Medicine, University of Kansas Medical Center, Kansas City, Kan.

Footnotes
Received for publication Oct 2, 1975; accepted March 9, 1976.

Reprint requests to Section of Endocrinology and Metabolism, Department of Medicine, University of Kansas Medical Center, Kansas City, KS 66103 (Dr Lukert).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence
Rubin and Bilezikian
J. Clin. Endocrinol. Metab. 2002;87:4033-4041.
FULL TEXT  

Acute effects of etidronate on glucocorticoid-induced bone degradation
Struijs et al.
Rheumatology (Oxford) 2000;39:523-529.
ABSTRACT | FULL TEXT  

Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy
Kung et al.
Rheumatology (Oxford) 1999;38:1239-1244.
ABSTRACT | FULL TEXT  

Alterations of Bone Turnover and Bone Mass at Different Skeletal Sites due to Pure Glucocorticoid Excess: Study in Eumenorrheic Patients with Cushing's Syndrome
Chiodini et al.
J. Clin. Endocrinol. Metab. 1998;83:1863-1867.
ABSTRACT | FULL TEXT  

Randomized Trial of Effect of Cyclical Etidronate in the Prevention of Corticosteroid-Induced Bone Loss
Roux et al.
J. Clin. Endocrinol. Metab. 1998;83:1128-1133.
ABSTRACT | FULL TEXT  

Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells
Rubin et al.
Endocrinology 1998;139:1006-1012.
ABSTRACT | FULL TEXT  

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert and Raisz
ANN INTERN MED 1990;112:352-364.
ABSTRACT  

Recovery from Steroid-Induced Osteoporosis
POCOCK et al.
ANN INTERN MED 1987;107:319-323.
ABSTRACT  

Corticosteroid-Induced Osteopenia
Hahn
Arch Intern Med 1978;138:882-885.
ABSTRACT